Nectar Lifesciences announced an 81 crore rupee share buyback. The record date has been set for December 24. The share price rose by up to 18% in intra-day trade. Investors are likely to benefit from this buyback.
Nectar Lifesciences Share: Shares of the pharmaceutical company Nectar Lifesciences Limited surged by up to 18 percent in intra-day trade on Thursday (December 4). This rally was triggered by the company's board approving an 81 crore rupee share buyback and finalizing the record date. A share buyback means that the company repurchases its own shares from its shareholders or the market.
At 2 PM on BSE, Nectar Lifesciences shares were trading at 21 rupees per share, up by 3.08 rupees or 17.19 percent. During the same period, the BSE Sensex was trading at 85,048.11, down by 0.07 percent.
Company Announces Buyback
Nectar Lifesciences' board has approved an 81 crore rupee share buyback. The buyback price has been set at 27 rupees per share. The company will repurchase a total of 3 crore shares, which constitutes 13.38 percent of its paid-up share capital.
The record date for the share buyback has been fixed as December 24, 2025. This offer is open to all shareholders, but promoters and the promoter group are excluded. The share buyback will be conducted through a tender offer. If an investor offers more shares than specified, shares will be purchased on a proportionate basis.
What Does Nectar Lifesciences Do?
Nectar Lifesciences is one of India's leading Active Pharmaceutical Ingredient (API) manufacturing companies. Previously a small domestic API company, it has now become one of the most integrated companies in the global cephalosporin market within the anti-infective segment. The company has a b presence in both APIs and formulations, conducting business in approximately 45 countries.
Share Trading 60% Below its High
Nectar Lifesciences' share is currently trading approximately 60 percent below its 52-week high of 44.90 rupees. The 52-week low was recorded at 17.92 rupees.
Looking at recent performance, the share has surged by 48 percent in one month. It has seen a rise of 43.29 percent in three months. However, the share has fallen by 13.48 percent in six months and 38.95 percent in one year. Over two years, the share has seen a decline of 29.08 percent. The stock's performance has remained largely flat over three and five years.
Importance of Buyback for Investors
A share buyback offers a beneficial opportunity for investors. Under this, the company repurchases its shares at a predetermined price, providing immediate benefits to shareholders and increasing the value of the company's remaining shares. Nectar Lifesciences' buyback offer has the potential to provide investors with good returns along with security.
Opportunities in the Pharma Sector
Nectar Lifesciences is benefiting from the increasing demand for companies in the pharmaceutical sector and its expansion in the global market. Its b presence in both APIs and formulations, coupled with its penetration into global markets, has boosted the company's growth. Shares like these can offer good returns to investors over the long term.











